CancerNetwork
Oncology On The Go
Oncology On The Go is a weekly podcast that talks to authors and experts to thoroughly examine featured articles in the journal ONCOLOGY and review other challenging treatment scenarios in the cancer field from a multidisciplinary perspective. Our discussions also offer timely insight into topics ranging from recent FDA approvals to relevant research presented at major oncology conferences. As the home of the journal ONCOLOGY, CancerNetwork offers different perspectives on oncology/hematology through review articles, news, podcasts, blogs, and more. To learn more, you can also visit us on Face...
Be sure to visit the podcast's website and support the creator: www.cancernetwork.com
Author
CancerNetwork
Category
Podcast website
Latest episode
Nov 16, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
S1 Ep93: Jyoti S. Mayadev, MD, on Pembrolizumab/CRT FDA Approval in Cervical Cancer 22.01.2024 9:57
In a conversation with CancerNetwork® prior to the FDA approval of pembrolizumab (Keytruda) plus chemoradiotherapy in FIGO stage III to IVA cervical cancer, Jyoti S. Mayadev, MD, spoke about how the regimen’s approval would be a “major step” for the aforementioned population and how she planned to integrate it into her care.1 Mayadev, a board-certified radiation oncologist and professor of radiat...
S1 Ep92: Managing CDK4/6 Inhibitor, ADC Toxicity in Metastatic Breast Cancer 15.01.2024 22:10
In a conversation with CancerNetwork®, Sarah Donahue, MPH, NP, discussed strategies for managing adverse effects (AEs) associated with different drug classes for patients with metastatic breast cancer, ranging from antibody drug conjugates (ADCs) to CDK4/6 inhibitors. With respect to ADCs, Donahue, a nurse practitioner at University of California, San Francisco, and member of the Oncology Nursing...
S1 Ep91: HER2CLIMB-02 Trial Shows ‘Interesting Data’ in HER2+ Breast Cancer 09.01.2024 12:33
In a recent conversation with CancerNetwork®, Sara A. Hurvitz, MD, FACP, senior vice president and director of the Clinical Research Division at Fred Hutch Cancer Center and head of the Division of Hematology and Oncology at the University of Washington Department of Medicine, discussed new treatment options for patients with metastatic HER2-positive breast cancer. In the discussion, Hurvitz high...
S1 Ep90: Frontline Chemo-Free Regimen Supported in HR+/HER2+ Breast Cancer Therapy 01.01.2024 5:49
In a conversation with CancerNetwork®, Amy Tiersten, MD, spoke about how findings from the phase 1/2 ASPIRE trial (NCT03304080) may support anastrozole (Arimidex) plus palbociclib (Ibrance), trastuzumab (Herceptin), and pertuzumab (Perjeta) as a first-line treatment for patients with hormone receptor (HR)–positive, HER2-positive metastatic breast cancer. Data presented at the 2023 San Antonio Brea...
S1 Ep89: Expert Discusses Screening Advocacy, AI, and Developments in Breast Cancer 18.12.2023 24:25
In a conversation with CancerNetwork®, Rakshanda Rahman, MD, FRCS, FACS, discussed a wide range of surgical therapy strategies and other developments in the breast cancer space, ranging from factors that should be considered for surgical decision-making to the evolution of artificial intelligence (AI) in the field. Rahman, a professor of Breast Surgical Oncology at Texas Tech University Health Sci...
S1 Ep88: Joleen Hubbard, MD, Highlights The “Exciting Space” Of Metastatic CRC 11.12.2023 9:03
In a recent discussion with CancerNetwork®, Joleen Hubbard, MD, research collaborator with Mayo Clinic and deputy director for clinical research at Allina Health Cancer Institute in Minneapolis, Minnesota, discussed new opportunities for patients with colorectal cancer (CRC). In the discussion, Hubbard highlighted the potential of trastuzumab deruxtecan-nxki (Enhertu; T-DXd) in patients with HER...
S1 Ep87: Adapting to a Robotic Workstation for Image-Guided Liver Cancer Surgery 04.12.2023 13:24
CancerNetwork® spoke with Govindarajan Narayanan, MD about his practice becoming the first in the United States to successfully surgically treat a patient with a liver tumor using the Epione robot, as well as the process of transitioning from CT-based image guidance to the robotic workstation in his care.1 Narayanan, a professor of Radiology and an interventional radiologist at Miami Cardiac and...
S1 Ep86: Tanios S. Bekaii-Saab, MD, Speaks to Expanding Horizons in CRC Treatment 27.11.2023 8:04
During an overview of the current standard of care for patients with colorectal cancer (CRC) , Tanios S. Bekaii-Saab, MD noted that as molecular testing becomes more important, researchers are looking into how to best personalize therapy for optimal outcomes. He spoke with CancerNetwork® as part of an Around the Practice® program focused on testing and treatment options for patients with metastati...
S1 Ep85: Multidisciplinary Care and New Treatment Options in CRC 20.11.2023 5:00
Kristen K. Ciombor, MD, MSCI, an assistant professor in the Division of Hematology/Oncology in the Department of Medicine at the Vanderbilt University Medical Center, recently spoke at an Around the Practice discussion regarding updates in the world of metastatic colorectal cancer (CRC). In this episode of the ONCOLOGY® On the Go Podcast, she discusses treatment updates, molecular testing options,...
S1 Ep84: Multidisciplinary Care, Approval Updates, and Future Research in NSCLC 13.11.2023 10:53
As part of an Around the Practice program, CancerNetwork® spoke with Misako Nagasaka, MD, PhD, about her current treatment strategies for patients with lung cancer as well as relevant updates and potential advancements in the non–small cell lung cancer (NSCLC) space. Nagasaka, a thoracic oncologist and associate clinical professor at the University of California, Irvine, discussed sequencing immun...
S1 Ep83: Psychosocial Approach to Sexual Dysfunction During and After Cancer Treatment 08.11.2023 11:19
Sexual dysfunction is a common problem for patients with and survivors of cancer that often remains undertreated. It can manifest in a variety of ways, including reduced libido, sexual pain, and vaginal dryness. Jennifer A. Vencill, PhD, LP, takes a biopsychosocial approach to sexual health, helping to address the psychological aspects of sexual dysfunction. In this episode of the ONCOLOGY On the...
S1 Ep82: Experts Discuss Differences in Radiotherapy Outcomes in BRCA+ Breast Cancer 30.10.2023 16:20
During Breast Cancer Awareness Month 2023, Rebecca M. Shulman, MD, an assistant professor in the Department of Radiation Oncology at Fox Chase Cancer Center, and Zachary Kiss, DO, a third-year resident physician in radiation oncology at Fox Chase, spoke about findings from their study, which assessed how BRCA1/2 mutations in patients with breast cancer do not appear to affect treatment outcomes...
S1 Ep81: Pipeline Perspectives: Fruquintinib in Metastatic Colorectal Cancer 02.10.2023 21:03
In this episode of the ONCOLOGY On the Go Podcast, Arvind N. Dasari, MD, and Cathy Eng, MD, speak to data supporting fruquintinib (Elunate), a VEGFR-1, -2, and -3 inhibitor as a potential treatment for patients with metastatic colorectal cancer (CRC). Dasari is an associate professor in the Department of Gastrointestinal Medical Oncology in the Division of Cancer Medicine at The University of Tex...
S1 Ep80: Navigating the Impact of Chemotherapy Shortages on Cancer Care and Finances 11.09.2023 21:55
CancerNetwork® spoke with experts across multiple disciplines about the far-reaching impacts of the ongoing shortages of chemotherapy drugs including carboplatin and cisplatin, and how practices may be able to mitigate these challenges in the short and long term. Michael Ganio, PharmD, MS, BCPS, FASHP, described the causes of carboplatin and cisplatin being in short supply across the United State...
S1 Ep79: Frontline Forum: Testing and Targeted Therapy in EGFR Exon20+ NSCLC 04.09.2023 54:10
As part of a CancerNetwork® Frontline Forum program, Alexander I. Spira, MD, PhD, FACP; Millie Das, MD; Joshua K. Sabari, MD; and Misako Nagasaka, MD, PhD, reviewed updates in the management of EGFR exon 20 non–small cell lung cancer (NSCLC), and how these findings may apply to clinical practice. Spira, codirector of the Virginia Cancer Specialists Research Institute and director of the Thoracic...
S1 Ep78: Frontline Forum: Real-World Practice in Newly Diagnosed Multiple Myeloma 14.08.2023 49:29
As part of a CancerNetwork® Frontline Forum program, Joselle Cook, MBBS; Matthew James Pianko, MD; Luciano Costa, MD, PhD; and Timothy Schmidt, MD, reviewed key data updates and real-world practice findings in newly diagnosed multiple myeloma (NDMM), and how they may impact patient subgroups including those with transplant-ineligible NDMM. Cook, a hematologist specializing in the management of pat...
S1 Ep77: Relapsed/Refractory Multiple Myeloma Trial Updates From ASCO 2023 07.08.2023 32:46
In a Twitter Spaces edition of the Oncology-On-The-Go podcast, Rafael Fonseca, MD and Krina Patel, MD, MSc spoke with CancerNetwork® about how key findings from multiple myeloma trials presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting may impact the treatment paradigm. Fonseca, director of Innovation and Transformation Relationships at the Mayo Clinic in Phoenix, A...
S1 Ep76: Sarcoma Awareness Month 2023 with Brian Van Tine, MD, PhD 31.07.2023 13:16
In a conversation with CancerNetwork® during July’s Sarcoma Awareness Month 2023 , Brian Van Tine, MD, PhD, spoke about developments in the sarcoma research space and discussed where future research needs to be focused in order to push the needle forward in the treatment of this patient across numerous sarcoma subgroups. Van Tine, a professor of medicine in the Division of Oncology, Section of Med...
S1 Ep75: Oncology On-The-Go Podcast: Secondary Cancer Susceptibility in Cancer Survivors 27.06.2023 20:12
In a conversation with CancerNetwork® during June’s National Cancer Survivor Month, Lindsay Morton, PhD, spoke about her research on the long-term risks of developing second cancers among cancer survivors. Morton, director of the Radiation Epidemiology Branch and head of the Cancer Survivorship Research Unit at the National Cancer Institute and member of the Lymphoma Research Foundation’s Scientif...
S1 Ep74: Oncology On-The-Go Podcast: ASCO 2023 Recap 19.06.2023 39:46
Ritu Salani, MD, and Tanios S. Bekaii-Saab, MD, FACP, spoke with CancerNetwork® about key findings presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting , and how they may affect clinical practice for gynecologic cancer and gastrointestinal cancer. Salani, the Gynecologic Oncology Fellowship Director at University of California Los Angeles (UCLA) Health and the Gynecolo...
S1 Ep73: Oncology On-The-Go Podcast: Nursing-Led Palliative Care in Advanced Cancer 15.05.2023 10:22
Margaret Rosenzweig, PhD, CRNP-C, AOCNP, FAAN, spoke with CancerNetwork® about findings from the CONNECT study (NCT02712229) , a study she authored that aimed to assess the benefit of palliative care intervention in patients with advanced cancer. Rosenzweig, the distinguished service professor of nursing and a professor of medicine at the Hillman Cancer Center Acute & Tertiary Care, University...
S1 Ep72: Oncology On-The-Go Podcast: De-escalating Breast Cancer Treatment 08.05.2023 18:18
Rakhshanda Rahman, MD, FRCS, FACS, interviewed with CancerNetwork® regarding advancements in the systemic and surgical de-escalation of breast cancer treatment, which include wire-free markers that help define the extent of a tumor during surgery. Rahman, a professor of Breast Surgical Oncology at Texas Tech University Health Sciences Center and the medical director of UMC Cancer Center, discussed...
S1 Ep71: Oncology-On-The-Go Podcast: Signaling Pathways in Glioblastoma Relapse 01.05.2023 21:39
Javier Orozco-Mera, MD, FACS, MSc, a neurosurgeon in the Department of Neurosurgery at Hospital Universitario del Valle “Evaristo García,” University of Valle, spoke with CancerNetwork® about his study titled, Signaling Pathways in the Relapse of Glioblastoma, which was published in the journal ONCOLOGY ®. In his study, Orozco-Mera and his colleagues identified a several signaling pathways and mol...
S1 Ep70: Oncology On-The-Go Podcast: SGO 2023 Recap 24.04.2023 40:15
In a Twitter Spaces edition of the Oncology On-The-Go podcast, Ritu Salani, MD, and Dana Chase, MD, spoke with CancerNetwork® about findings presented at the Society of Gynecologic Oncology (SGO) 2023 Annual Meeting on Women’s Cancer, and how they may impact clinical practice. Salani, the Gynecologic Oncology Fellowship Director at University of California Los Angeles (UCLA) Health and the Gynecol...
S1 Ep69: Oncology On-The-Go Podcast: COVID-19 Vaccination and Cellular Therapy in Cancer 17.04.2023 19:24
Fareed Khawaja, MBBS, assistant professor in the Department of Infectious Diseases, Infection Control, and Employee Health at The University of Texas MD Anderson Cancer Center, and Marilyne Daher, MD, medical resident in the Department of Internal Medicine at Baylor College of Medicine, spoke with CancerNetwork® about their study titled COVID-19 Vaccination in Patients with Cancer and Recipients o...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.